Claims for Patent: 8,785,142

Summary for Patent: 8,785,142

Title:	Test arrangement
Abstract:	The invention relates to an arrangement, comprising a solid carrier and a matrix arranged on the solid carrier, said matrix comprising at least one enzymatically convertible or modifiable molecule and comprising at least one enzyme that can be released by the conversion or modification of the molecule, said enzyme being capable of converting at least one color-changing substrate located in the matrix and/or on the solid carrier.
Inventor(s):	Gubitz; Georg (Hart bei Graz, AT), Sigl; Eva (Gro.beta. Veitsch, AT), Hasmann; Andrea (Graz, AT), Schroder; Marc (Heinerscheid, LU), Schneider; Konstantin (Graz, AT), Rollett; Alexandra (Graz, AT), Kaufmann; Franz (Freiburg, DE), Hafner; Andreas (Gelterkinden BL, CH)
Assignee:	Sigl; Eva (Gross Veitsch, AT)
Application Number:	13/577,366
Patent Claims:	1. An arrangement comprising a solid carrier and a matrix arranged on the solid carrier, the matrix comprising at least one trigger enzyme convertible or modifiable molecule and at least one amplifier enzyme that can be released by conversion or modification of the molecule, wherein the amplifier enzyme converts at least one colour-changing immobilized substrate located in the matrix and/or on the solid carrier after the amplifier enzyme is released. 2. The arrangement according to claim 1, characterised in that the matrix is arranged as a layer, in the form of capsules or as a hydrogel on the solid carrier. 3. The arrangement according to claim 1, characterised in that the enzymatically convertible or modifiable molecule is a polymer. 4. The arrangement according to claim 3, characterised in that the polymer is a polysaccharide, polypeptide, polyester, polyamide or a combination thereof. 5. The arrangement according to claim 4, characterised in that the polysaccharide is selected from the group consisting of pectin, amylose, amylopectin, agarose, alginate, carrageenan, chitin, chitosan, dextran, glycogen, locust bean gum, levan, pollulan, xanthan and xylan. 6. The arrangement according to claim 3, characterised in that the polymer is selected from the group consisting of, agar, agarose, maltodextrins, alginic acid and salts thereof, sodium alginate, calcium alginate, collagen, chitosan, peptidoglycan, gelatins, albumin, shellac, polysaccharides, starch, dextran, cyclodextrins, pectin, and carragenan. 7. The arrangement according to claim 3, characterised in that the polymer, the amplifier enzyme and the colour-changing substrate are selected from Table A. 8. The arrangement according to claim 1, characterised in that the amplifier enzyme is conjugated to polyvinyl alcohol, polyethylene glycol (PEG), polypeptide, elastin or a peptide. 9. The arrangement according to claim 8, characterised in that the amplifier enzyme is conjugated by means of a polypeptide or peptide to the enzymatically convertible or modifiable molecule, and wherein the trigger enzyme is selected from the group consisting of a microbial enzyme, an enzyme of the immune system and elastase. 10. The arrangement according to claim 1, characterised in that the colour-changing substrate is selected from the group consisting of phenolic compounds and azo dyes. 11. The arrangement according to claim 10, characterised in that the colour-changing substrate can be converted directly by an amplifier enzymes selected from the group consisting of microbial enzymes, laccases, peroxidases, enzymes of the immune system, and myeloperoxidase. 12. The arrangement according to claim 1, characterised in that the arrangement comprises a semi-permeable membrane opposite the solid carrier. 13. The arrangement according to claim 12, characterised in that the semi-permeable membrane is selected from the group consisting of cellulose derivatives, polyamides, polyacrylamides and polyester. 14. The arrangement according to claim 1, characterised in that the solid carrier comprises a material which is selected from the group consisting of inorganic materials, silica gel, aluminium, silicon, glass, organic materials, polyester, polystyrene, polyamide, polyacrylamide, polyvinyl alcohol, biopolymers, and paper. 15. A method of determining the presence of cells of interest in a sample comprising: applying the sample to the arrangement of claim 1, and detecting the presence or absence of a change in colour in the colour-changing substrate, wherein the convertible or modifiable molecule of the arrangement is modified or converted by a trigger enzyme produced by the cells of interest and the presence of a change in colour of the colour-changing substrate indicates that the cells of interest are present in the sample, and the absence of a change in colour of the colour-changing substrate indicates the cells of interest are absent in the sample. 16. The method of claim 15 wherein the cells are microorganisms. 17. The method of claim 16 wherein the microorganisms are selected from the group consisting of bacteria and fungi. 18. A method of detecting at least one trigger enzyme in a sample comprising: applying the sample to the arrangement of claim 1, and detecting the presence or absence of a change in colour of the colour-changing substrate, wherein the convertible or modifiable molecule of the arrangement is modified or converted by the at least one trigger enzyme of interest and the presence of a change in colour of the colour-changing substrate indicates the at least one trigger enzyme of interest is present in the sample, and the absence of a change in colour of the colour-changing substrate indicates the at least one trigger enzyme of interest is absent in the sample. 19. A method of detecting wound infection by determining the presence of at least one wound-specific trigger enzyme in a sample comprising: applying the sample to the arrangement of claim 1, and detecting the presence or absence of the colour-changing substrate, wherein the convertible or modifiable molecule of the arrangement is modified or converted by the at least one wound-specific trigger enzyme and the presence of a change in colour of the colour-changing substrate indicates the at least one wound-specific trigger enzyme is present in the sample, and the absence of a change in colour of the colour-changing substrate indicates the at least one wound-specific trigger enzyme is absent in the sample. 20. The method of claim 19, wherein the at least one wound-specific trigger enzyme is selected from the group consisting of amylase, cellulase, xylanase, mannanase, protease, lysozyme, elastase, collagenase, and cathepsin. 21. The arrangement according to claim 1, wherein the amplifier enzyme is selected from the group consisting of a protease, a laccase, and a peroxidase.

Details for Patent 8,785,142

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2030-02-10